Avidity Partners Management LP Buys 141,800 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Avidity Partners Management LP raised its holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 28.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 643,000 shares of the biotechnology company’s stock after purchasing an additional 141,800 shares during the quarter. […]